US big company (Cephalon) takeover bid last year at $4.8 prove the credibility of Sirtex liver cancer treatment tech. There is not much competitor on its product either. Only one other company Nordion, is developing similar drug.
At $3 marks, SRX looks cheap. I'm sure Cephalon is watching and may put another offer on the table.
Comments welcome.
I hold lots.
US big company (Cephalon) takeover bid last year at $4.8 prove...
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.3¢ | $395.4K | 2.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2728183 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 84474 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |